Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |